TACRINE

Description: Tacrine acts inactivates cholinesterase, inhibiting hydrolysis of acetylcholine, prolonging their action in the brain.

Mild to moderate dementia (eg, impairment of memory or judgement, abstract thinking, changes in personality) in patients with Alzheimer disease.

Tacrine is a cholinesterase inhibitor and it increases the amount of a certain substance (acetylcholine) in the brain.

Tacrine has been assigned to pregnancy category C by the FDA.

No data on the excretion of tacrine into human milk.

  • Increased alanine aminotransferase (ALT) as a result fo liver damageĀ *adjust dose
  • nausea
  • indigestion
  • vomiting
  • diarrhea
  • abdominal pain
  • skin rash

Precautions

Safety and effectiveness have not been established in pediatric patients (less than 18 years of age).

 

Drug Interactions

  • Atropine
  • benztropine (Cogentin)
  • trihexyphenidyl (Artane)

Dosing

  • Recommended dose: 10 to 20 mg four times daily
  • Maximum dose: 160 mg daily
  • Tacrine is usually taken on an empty stomach (one hour before, or two hours after meals) unless it causes stomach upset

Storage: Capsules should be stored at room temperature, 15-30 C (59-86 F).

Related Articles

LESINURAD

Lesinurad suppresses the enzymes uric acid transporter 1 (URAT1) and organic anion carrier 4 (OAT4), which increases uric acid outflow [...]

LEMBOREXANT

Lemborexant is an orexin potent inhibitor that's competitive. It is considered to prevent the attachment of wake-promoting neurotrophins orexin A [...]

INSULIN LISPRO + INSULIN LISPRO PROTAMINE

Insulin lispro is a fast-acting human insulin alternative, whereas insulin lispro protamine is a slow-acting human insulin alternative. They both [...]